DEA Notification Act of 2018

Bill Number

HR 7369

Introduced

Dec 20, 2018

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary ...

Sponsor

Cosponsors

Topics

Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Health Health care quality Health facilities and institutions Licensing and registrations Medicare Prescription drugs

Full Text

View Full Bill Text

Votes

Summary

DEA Notification Act of 2018

This bill requires the Centers for Medicare & Medicaid Services to notify the Drug Enforcement Administration (DEA) of providers or suppliers that are prohibited from participating in Medicare due to improper prescriptions of controlled substances, and to recommend that the DEA consider revoking certain controlled substance registrations or waivers held by such providers or suppliers.

Actions

Dec 20, 2018

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 20, 2018

Introduced in House

Amendments

Related Bills